Results 181 to 190 of about 1,649,512 (376)

A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation. [PDF]

Leuk Lymphoma, 2019
Bezerra ED, Flowers ME, Onstad LE, Chielens D, Radich J, Higano CS.   +5 more
europepmc   +1 more source

Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages [PDF]

, 1992
Maja Matić, Sanford R. Simon
openalex   +1 more source

Characterization of the Alpha Interferon-Induced Postentry Block to HIV-1 Infection in Primary Human Macrophages and T Cells

Journal of Virology, 2010
C. Goujon, M. Malim
semanticscholar   +1 more source

Wedelolactone, a Novel TLR2 Agonist, Promotes Neutrophil Differentiation and Ameliorates Neutropenia: A Multi‐Omics Approach to Unravel the Mechanism

Advanced Science, EarlyView.
Wedelolactone (WED), a natural TLR2 agonist, promotes neutrophil differentiation and enhances bactericidal function, offering a potential therapeutic strategy for neutropenia. Using a multi‐omics approach, this study reveals that WED activates the TLR2/MEK/ERK pathway, upregulating key transcription factors (PU.1, CEBPβ) to drive neutrophil development.
Long Wang, Zhichao Li, Tianci Hu, Qinyao Li, Linwei Zhang, Xinyue Mei, Xiao Qi, Sheng Liu, Weijie Kong, Jiesi Luo, Anguo Wu, Feihong Huang, Sirui Li, Shuang Dai, Chunxiang Zhang, Rong Li, Jianming Wu   +16 more
wiley   +1 more source

IFNA2: The prototypic human alpha interferon. [PDF]

Gene, 2015
Paul F, Pellegrini S, Uzé G.
europepmc   +1 more source

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia [PDF]

, 1987
Carmelo Carlo‐Stella, Mario Cazzola, A Gasner, Giovanni Barosi, Laura Dezza, Federica Meloni, Paolo Pedrazzoli, D. Hoelzer, E Ascari   +8 more
openalex   +1 more source

Comparison of Immune Restoration in Early versus Late Alpha Interferon Therapy against Hepatitis C Virus

Journal of Virology, 2010
Mohamed S. Abdel-Hakeem, N. Bédard, Gamal Badr, M. Ostrowski, R. Sékaly, J. Bruneau, B. Willems, E. Heathcote, N. Shoukry   +8 more
semanticscholar   +1 more source

A Novel FGFR3‐Targeting Antibody‐Drug Conjugate Induces Tumor Cell Apoptosis through the cGAS–STING Pathway in Bladder Cancer

Advanced Science, EarlyView.
LZU‐WZLYCS01 is a novel FGFR3‐targeting ADC for bladder cancer with 7‐ethyl‐9‐fluorocamptothecin (A2) as its cytotoxic payload. LZU‐WZLYCS01 intracellularly releases A2, which targets MAD2L1 to activate the cGAS‐STING pathway and induce tumor cell apoptosis.
Shu Cui, Xiongfei Luo, Guangrui Fan, Jingqi Jiang, Yingru Wang, Enguang Yang, Jinpeng Ma, Ze Zhang, Yuhan Wang, Juan Wang, Dengtuo Wang, Hanzhang Wang, Liang Cheng, Junqiang Tian, Zhilong Dong, Yingqian Liu, Zhiping Wang   +16 more
wiley   +1 more source

Very long‐term follow‐up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy

, 2012
Hagop M. Kantarjian, Susan O’Brien, Guillermo Garcia‐Manero, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Jianqin Shan, Jörge E. Cortes   +7 more
openalex   +2 more sources

The woodchuck interferon alpha system: cloning, family description and biologic activity [PDF]

, 2002
Pedro Berraondo, Raquel García‐Navarro, Gloria González‐Aseguinolaza, África Vales, Laura Ochoa‐Callejero, B. Blanco-Urgoiti, Esther Larrea, José Ignacio Riezu‐Boj, Jesús Prìeto, Juan D. Ruiz   +9 more
openalex   +1 more source